<scp>EAACI</scp> Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma

Agache, Ioana; Lau, Susanne; A. Akdiş, Cezmi; Smolińska, Sylwia; Bonini, Matteo; Cavkaytar, Özlem; Flood, Breda; Gajdanowicz, Paweł; Izuhara, Kenji; Kalaycı, Ömer; Mösges, Ralph; Palomares, Óscar; G. Papadopoulos, Nikolaos; Sokołowska, Milena; Angier, Elizabeth; Fernández‐Rivas, Montserrat; Battista Pajno, Giovanni; Pfaar, Oliver; Roberts, Graham; Ryan, Dermot; J. Sturm, Gunter; van Ree, Ronald; Varga, E.‐M.; Gerth van Wijk, Roy; José Yepes-Núñez, Juan; Jutel, Marek

doi:10.1111/all.13749

Public

EAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma

Published in Allergy • May 1, 2019

Authors:

Ioana Agache

Susanne Lau

Cezmi A. Akdiş

Abstract

Allergen immunotherapy (AIT) has been in use for the treatment of allergic disease for more than 100 years. Asthma treatment relies mainly on corticosteroids and other controllers recommended to achieve and maintain asthma control, prevent exacerbations, and improve quality of life. AIT is underused...

Subject

Medicine

Asthma

Allergen immunotherapy

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!